MMS - Maximus, Inc. Stock Analysis | Stock Taper
Logo
Maximus, Inc.

MMS

Maximus, Inc. NYSE
$61.93 -1.51% (-0.95)

Market Cap $3.25 B
52w High $100.00
52w Low $56.92
Dividend Yield 1.34%
Frequency Quarterly
P/E 9.30
Volume 504.40K
Outstanding Shares 52.54M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2026 $1.31B $173.48M $98.06M 7.51% $1.81 $181.11M
Q1-2026 $1.35B $161.14M $93.94M 6.98% $1.71 $178.59M
Q4-2025 $1.32B $187M $75.29M 5.71% $1.34 $160.07M
Q3-2025 $1.35B $170.76M $105.98M 7.86% $1.87 $198.24M
Q2-2025 $1.36B $162.86M $96.57M 7.09% $1.7 $186.37M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2026 $244.7M $4.24B $2.54B $1.7B
Q1-2026 $137.59M $4.21B $2.49B $1.72B
Q4-2025 $260.46M $4.07B $2.4B $1.67B
Q3-2025 $105.38M $4.46B $2.69B $1.77B
Q2-2025 $155.94M $4.2B $2.53B $1.67B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2026 $98.06M $189.53M $-10.51M $-113.28M $65.17M $179.02M
Q1-2026 $93.94M $-244.4M $6.63M $156.9M $-80.93M $-250.66M
Q4-2025 $75.29M $649.37M $-3.15M $-490.67M $116.97M $641.85M
Q3-2025 $105.98M $-182.72M $-15.49M $146.12M $-50.56M $-198.21M
Q2-2025 $96.57M $42.71M $-19.37M $8.93M $33.07M $25.51M

Revenue by Products

Product Q3-2025Q4-2025Q1-2026Q2-2026
Clinical Services
Clinical Services
$560.00M $570.00M $520.00M $530.00M
Technology Solutions
Technology Solutions
$80.00M $0 $70.00M $70.00M

Revenue by Geography

Region Q1-2022Q2-2022Q3-2022Q4-2022
AUSTRALIA
AUSTRALIA
$50.00M $50.00M $40.00M $30.00M
Rest Of World
Rest Of World
$40.00M $50.00M $50.00M $40.00M
UNITED KINGDOM
UNITED KINGDOM
$90.00M $110.00M $110.00M $110.00M
UNITED STATES
UNITED STATES
$970.00M $970.00M $920.00M $1.00Bn

Q2 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Maximus, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Core strengths include steady revenue growth, a sharp recovery in margins and earnings, strong and recurring operating cash flow, and a solid niche position in government services. Long-standing relationships with public agencies, combined with growing technology capabilities, create meaningful barriers to entry. Liquidity has improved, giving the company more flexibility to manage working capital, invest selectively, and support shareholder returns.

! Risks

Risks center on sizable and somewhat variable debt levels, volatile free cash flow and capital spending, and rising overhead costs that could pressure margins if not controlled. The business is also exposed to contract concentration, competitive bidding, and shifts in government policy or funding, which can affect both revenue visibility and pricing. The lack of a formal R&D line makes it harder to track innovation investment, raising questions about how consistently it will be funded over time.

Outlook

The overall picture points to a company that has emerged from a weaker period into stronger growth and profitability, with innovation‑driven offerings that resonate with government clients. If Maximus can maintain cost discipline, manage leverage prudently, and keep advancing its technology and analytics capabilities, it appears well positioned to pursue additional contract wins and incremental margin gains. However, its future path will remain closely tied to government spending trends, competitive dynamics in federal and state contracting, and management’s choices around debt, buybacks, and investment intensity.